

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.64965908 |
| 2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.20280632 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.09257120 |
| 4 | creatine metabolic process (GO:0006600) | 3.60471278 |
| 5 | negative thymic T cell selection (GO:0045060) | 3.54383479 |
| 6 | negative regulation of inclusion body assembly (GO:0090084) | 3.46944883 |
| 7 | central nervous system myelination (GO:0022010) | 3.41703786 |
| 8 | axon ensheathment in central nervous system (GO:0032291) | 3.41703786 |
| 9 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.41274259 |
| 10 | negative T cell selection (GO:0043383) | 3.40323262 |
| 11 | germinal center formation (GO:0002467) | 3.33856874 |
| 12 | detection of bacterium (GO:0016045) | 3.32604142 |
| 13 | detection of other organism (GO:0098543) | 3.30879522 |
| 14 | B cell receptor signaling pathway (GO:0050853) | 3.29874794 |
| 15 | response to muramyl dipeptide (GO:0032495) | 3.24199427 |
| 16 | neutrophil activation involved in immune response (GO:0002283) | 3.18568036 |
| 17 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.15103683 |
| 18 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.11253237 |
| 19 | positive regulation of B cell differentiation (GO:0045579) | 3.09289900 |
| 20 | neuronal action potential propagation (GO:0019227) | 3.05036077 |
| 21 | leukocyte aggregation (GO:0070486) | 2.98423388 |
| 22 | positive regulation by symbiont of host defense response (GO:0052509) | 2.97908875 |
| 23 | modulation by symbiont of host defense response (GO:0052031) | 2.97908875 |
| 24 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.97908875 |
| 25 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.97908875 |
| 26 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.97908875 |
| 27 | modulation by symbiont of host immune response (GO:0052553) | 2.97908875 |
| 28 | skeletal muscle contraction (GO:0003009) | 2.95245802 |
| 29 | response to peptidoglycan (GO:0032494) | 2.87237055 |
| 30 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.86895249 |
| 31 | macrophage activation involved in immune response (GO:0002281) | 2.86174483 |
| 32 | cellular extravasation (GO:0045123) | 2.84805822 |
| 33 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.83451993 |
| 34 | negative regulation of cell killing (GO:0031342) | 2.81587048 |
| 35 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.81587048 |
| 36 | mannose metabolic process (GO:0006013) | 2.76939001 |
| 37 | ensheathment of neurons (GO:0007272) | 2.76583389 |
| 38 | axon ensheathment (GO:0008366) | 2.76583389 |
| 39 | myelination (GO:0042552) | 2.75687717 |
| 40 | fatty acid elongation (GO:0030497) | 2.74633841 |
| 41 | potassium ion import (GO:0010107) | 2.74192114 |
| 42 | detection of external biotic stimulus (GO:0098581) | 2.74015976 |
| 43 | positive regulation of granulocyte differentiation (GO:0030854) | 2.73790790 |
| 44 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.69688771 |
| 45 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.68563863 |
| 46 | regulation of necroptotic process (GO:0060544) | 2.65565308 |
| 47 | regulation of ARF protein signal transduction (GO:0032012) | 2.63865601 |
| 48 | negative regulation of T cell mediated immunity (GO:0002710) | 2.62905129 |
| 49 | T cell migration (GO:0072678) | 2.61274958 |
| 50 | activated T cell proliferation (GO:0050798) | 2.60251350 |
| 51 | regulation of skeletal muscle contraction (GO:0014819) | 2.59956160 |
| 52 | protein targeting to Golgi (GO:0000042) | 2.59770822 |
| 53 | signal complex assembly (GO:0007172) | 2.59288260 |
| 54 | regulation of leukocyte degranulation (GO:0043300) | 2.59269138 |
| 55 | regulation of B cell differentiation (GO:0045577) | 2.58241364 |
| 56 | establishment of protein localization to Golgi (GO:0072600) | 2.55688147 |
| 57 | cellular potassium ion homeostasis (GO:0030007) | 2.55439232 |
| 58 | Peyers patch development (GO:0048541) | 2.54894299 |
| 59 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.54894299 |
| 60 | regulation of mast cell degranulation (GO:0043304) | 2.53712806 |
| 61 | response to methylmercury (GO:0051597) | 2.52482008 |
| 62 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.50664391 |
| 63 | skeletal muscle adaptation (GO:0043501) | 2.47563381 |
| 64 | Golgi to endosome transport (GO:0006895) | 2.45185474 |
| 65 | myelin maintenance (GO:0043217) | 2.44615950 |
| 66 | angiogenesis involved in wound healing (GO:0060055) | 2.44275116 |
| 67 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.41796888 |
| 68 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.40142267 |
| 69 | response to laminar fluid shear stress (GO:0034616) | 2.39824400 |
| 70 | nerve growth factor signaling pathway (GO:0038180) | 2.38794858 |
| 71 | regulation of platelet aggregation (GO:0090330) | 2.37992561 |
| 72 | tolerance induction (GO:0002507) | 2.37813578 |
| 73 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.37695970 |
| 74 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.36401573 |
| 75 | type I interferon signaling pathway (GO:0060337) | 2.36125217 |
| 76 | cellular response to type I interferon (GO:0071357) | 2.36125217 |
| 77 | response to type I interferon (GO:0034340) | 2.35756039 |
| 78 | lipid translocation (GO:0034204) | 2.35359607 |
| 79 | phospholipid translocation (GO:0045332) | 2.35359607 |
| 80 | skeletal muscle fiber development (GO:0048741) | 2.35214384 |
| 81 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.35115449 |
| 82 | detection of biotic stimulus (GO:0009595) | 2.35034762 |
| 83 | response to lipoprotein particle (GO:0055094) | 2.34626557 |
| 84 | muscle filament sliding (GO:0030049) | 2.34479607 |
| 85 | actin-myosin filament sliding (GO:0033275) | 2.34479607 |
| 86 | sodium ion export (GO:0071436) | 2.34234281 |
| 87 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.34042977 |
| 88 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.34042977 |
| 89 | B cell homeostasis (GO:0001782) | 2.33924912 |
| 90 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.31790001 |
| 91 | negative regulation of necroptotic process (GO:0060546) | 2.31116208 |
| 92 | positive regulation of receptor recycling (GO:0001921) | 2.30823453 |
| 93 | megakaryocyte development (GO:0035855) | 2.30227536 |
| 94 | detection of molecule of bacterial origin (GO:0032490) | 2.29218228 |
| 95 | desmosome organization (GO:0002934) | 2.28770026 |
| 96 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.28005072 |
| 97 | myeloid cell activation involved in immune response (GO:0002275) | 2.27210882 |
| 98 | immunoglobulin mediated immune response (GO:0016064) | 2.27033669 |
| 99 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.26475650 |
| 100 | regulation of beta-amyloid formation (GO:1902003) | 2.26256845 |
| 101 | positive T cell selection (GO:0043368) | 2.25838990 |
| 102 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.25652781 |
| 103 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.25652781 |
| 104 | negative regulation of innate immune response (GO:0045824) | 2.25559358 |
| 105 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.25250278 |
| 106 | response to host (GO:0075136) | 2.25222286 |
| 107 | response to host defenses (GO:0052200) | 2.25222286 |
| 108 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.25222286 |
| 109 | regulation of extracellular matrix disassembly (GO:0010715) | 2.24573068 |
| 110 | stress fiber assembly (GO:0043149) | 2.24322015 |
| 111 | protein localization to endosome (GO:0036010) | 2.22807355 |
| 112 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.22740985 |
| 113 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.22239583 |
| 114 | regulation of granulocyte differentiation (GO:0030852) | 2.22129599 |
| 115 | pinocytosis (GO:0006907) | 2.20664133 |
| 116 | positive thymic T cell selection (GO:0045059) | 2.20604953 |
| 117 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.20243736 |
| 118 | response to host immune response (GO:0052572) | 2.20211833 |
| 119 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.20211833 |
| 120 | cellular response to interleukin-15 (GO:0071350) | 2.18741685 |
| 121 | carnitine transmembrane transport (GO:1902603) | 2.18501931 |
| 122 | hypotonic response (GO:0006971) | 2.18248940 |
| 123 | NIK/NF-kappaB signaling (GO:0038061) | 2.18060970 |
| 124 | endoplasmic reticulum organization (GO:0007029) | 2.18025792 |
| 125 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.17902492 |
| 126 | glycine transport (GO:0015816) | 2.17753513 |
| 127 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.16592744 |
| 128 | regulation of collateral sprouting (GO:0048670) | 2.16581157 |
| 129 | synaptic vesicle maturation (GO:0016188) | 2.15954186 |
| 130 | regulation of T cell tolerance induction (GO:0002664) | 2.15749765 |
| 131 | negative regulation of acute inflammatory response (GO:0002674) | 2.15697224 |
| 132 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.15499512 |
| 133 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.14954787 |
| 134 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.14954787 |
| 135 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.14849542 |
| 136 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.14600286 |
| 137 | lymphocyte homeostasis (GO:0002260) | 2.14447888 |
| 138 | neutrophil activation (GO:0042119) | 2.14195384 |
| 139 | activation of protein kinase A activity (GO:0034199) | 2.13765700 |
| 140 | regulation of skeletal muscle cell differentiation (GO:2001014) | 2.12166174 |
| 141 | locomotory exploration behavior (GO:0035641) | 2.11934982 |
| 142 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.11887947 |
| 143 | import into cell (GO:0098657) | 2.10972540 |
| 144 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.10457841 |
| 145 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.09468394 |
| 146 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.08550993 |
| 147 | thymic T cell selection (GO:0045061) | 2.08402479 |
| 148 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.08296016 |
| 149 | regulation of ARF GTPase activity (GO:0032312) | 2.06058779 |
| 150 | carnitine shuttle (GO:0006853) | 2.05967386 |
| 151 | gamma-aminobutyric acid transport (GO:0015812) | 2.05132654 |
| 152 | neuromuscular junction development (GO:0007528) | 2.04889854 |
| 153 | mating behavior (GO:0007617) | 2.02462261 |
| 154 | potassium ion homeostasis (GO:0055075) | 2.02010668 |
| 155 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.01945164 |
| 156 | T cell selection (GO:0045058) | 2.01139277 |
| 157 | negative regulation of neurotransmitter transport (GO:0051589) | 2.00307754 |
| 158 | plasma membrane repair (GO:0001778) | 2.00282915 |
| 159 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.00128421 |
| 160 | myotube cell development (GO:0014904) | 1.99600207 |
| 161 | negative regulation of macroautophagy (GO:0016242) | 1.99262769 |
| 162 | membrane tubulation (GO:0097320) | 1.98162721 |
| 163 | L-amino acid import (GO:0043092) | 1.97101395 |
| 164 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 1.96408799 |
| 165 | regulation of gamma-delta T cell activation (GO:0046643) | 1.95759865 |
| 166 | amyloid precursor protein metabolic process (GO:0042982) | 1.95758292 |
| 167 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 1.95293394 |
| 168 | amino-acid betaine transport (GO:0015838) | 1.93942145 |
| 169 | carnitine transport (GO:0015879) | 1.93942145 |
| 170 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 1.93852766 |
| 171 | fatty-acyl-CoA metabolic process (GO:0035337) | 1.92713504 |
| 172 | response to interleukin-15 (GO:0070672) | 1.92661476 |
| 173 | vesicle targeting (GO:0006903) | 1.92239596 |
| 174 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 1.90675720 |
| 175 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 1.90341036 |
| 176 | cellular response to epinephrine stimulus (GO:0071872) | 1.89589693 |
| 177 | calcium ion import (GO:0070509) | 1.88451023 |
| 178 | actin-mediated cell contraction (GO:0070252) | 1.87240251 |
| 179 | regulation of lipoprotein metabolic process (GO:0050746) | 1.86807514 |
| 180 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 1.86337339 |
| 181 | response to epinephrine (GO:0071871) | 1.85494517 |
| 182 | positive regulation of Rap GTPase activity (GO:0032854) | 1.84842850 |
| 183 | membrane depolarization during action potential (GO:0086010) | 1.83662289 |
| 184 | regulation of cell communication by electrical coupling (GO:0010649) | 1.82853728 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.52482384 |
| 2 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.55042621 |
| 3 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.49892738 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 2.49657621 |
| 5 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.43967787 |
| 6 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.41273340 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.23696283 |
| 8 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.21584340 |
| 9 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.20528281 |
| 10 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.16110743 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.12960866 |
| 12 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.08664367 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.08346427 |
| 14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.06728285 |
| 15 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.06617140 |
| 16 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.04226796 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.03601528 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.02834553 |
| 19 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.01487167 |
| 20 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.01185725 |
| 21 | * MAF_26560356_Chip-Seq_TH1_Human | 2.00404752 |
| 22 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.99680119 |
| 23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97790981 |
| 24 | SPI1_23127762_ChIP-Seq_K562_Human | 1.96135066 |
| 25 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.90458789 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.88422363 |
| 27 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.82850451 |
| 28 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.80644422 |
| 29 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.80544935 |
| 30 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.79196588 |
| 31 | UTX_26944678_Chip-Seq_JUKART_Human | 1.76032271 |
| 32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.74307757 |
| 33 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.70872418 |
| 34 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.70708046 |
| 35 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.67921504 |
| 36 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.65448917 |
| 37 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.64401882 |
| 38 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.63298956 |
| 39 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.56875446 |
| 40 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.54215745 |
| 41 | MYB_26560356_Chip-Seq_TH2_Human | 1.53871469 |
| 42 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.51134948 |
| 43 | MAF_26560356_Chip-Seq_TH2_Human | 1.49593902 |
| 44 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.49501455 |
| 45 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.47799573 |
| 46 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.46998654 |
| 47 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.46895126 |
| 48 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.46300607 |
| 49 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.45917019 |
| 50 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.45884324 |
| 51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44440656 |
| 52 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.44419809 |
| 53 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.44419809 |
| 54 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.43231278 |
| 55 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.43015250 |
| 56 | MYB_26560356_Chip-Seq_TH1_Human | 1.42782409 |
| 57 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.42528917 |
| 58 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.41091160 |
| 59 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.40843628 |
| 60 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.40808375 |
| 61 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.40666089 |
| 62 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.40061100 |
| 63 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39851843 |
| 64 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.36446356 |
| 65 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.35303809 |
| 66 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.35099278 |
| 67 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.34401487 |
| 68 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.33610266 |
| 69 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.33598530 |
| 70 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33013140 |
| 71 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.29416730 |
| 72 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.27210676 |
| 73 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.24930985 |
| 74 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.24119095 |
| 75 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.23664457 |
| 76 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.23327990 |
| 77 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.22609319 |
| 78 | GATA1_22025678_ChIP-Seq_K562_Human | 1.20725915 |
| 79 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20470366 |
| 80 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.17462535 |
| 81 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.16633829 |
| 82 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.15845324 |
| 83 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.15732490 |
| 84 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15672246 |
| 85 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.14942983 |
| 86 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.14908776 |
| 87 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14475317 |
| 88 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.14438666 |
| 89 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.13530784 |
| 90 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12505743 |
| 91 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.12169083 |
| 92 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.12006609 |
| 93 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.11522768 |
| 94 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10398230 |
| 95 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.09912752 |
| 96 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.09537339 |
| 97 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.09426807 |
| 98 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.08122090 |
| 99 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.07874889 |
| 100 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07391478 |
| 101 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.06996602 |
| 102 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.06717907 |
| 103 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.06586962 |
| 104 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06340420 |
| 105 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.05945368 |
| 106 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.05275576 |
| 107 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.05124647 |
| 108 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.05106316 |
| 109 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.04852740 |
| 110 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.03517864 |
| 111 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02927364 |
| 112 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.02917680 |
| 113 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02462334 |
| 114 | RXR_22108803_ChIP-Seq_LS180_Human | 1.01568162 |
| 115 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.01030624 |
| 116 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.00329448 |
| 117 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00039929 |
| 118 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.99230987 |
| 119 | KDM2B_26808549_Chip-Seq_K562_Human | 0.98113587 |
| 120 | TP53_16413492_ChIP-PET_HCT116_Human | 0.97322165 |
| 121 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.95923382 |
| 122 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.94885988 |
| 123 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.94548270 |
| 124 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.93833326 |
| 125 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.92489017 |
| 126 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.90399338 |
| 127 | STAT3_23295773_ChIP-Seq_U87_Human | 0.90159557 |
| 128 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.89562943 |
| 129 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.89287967 |
| 130 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.89165166 |
| 131 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.88782185 |
| 132 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.88435002 |
| 133 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.88319102 |
| 134 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.88069135 |
| 135 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.87336753 |
| 136 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.86747571 |
| 137 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.86510475 |
| 138 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.85279106 |
| 139 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.83793313 |
| 140 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.83793313 |
| 141 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.83350171 |
| 142 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.83302696 |
| 143 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.83283154 |
| 144 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.82491737 |
| 145 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.82344124 |
| 146 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.81661291 |
| 147 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.81515264 |
| 148 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.81087896 |
| 149 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.80976811 |
| 150 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.80577362 |
| 151 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79949346 |
| 152 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.77909773 |
| 153 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.77808297 |
| 154 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.77703340 |
| 155 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.77417291 |
| 156 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.76498610 |
| 157 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.75914954 |
| 158 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.75777568 |
| 159 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.75706397 |
| 160 | TCF4_23295773_ChIP-Seq_U87_Human | 0.75641630 |
| 161 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.75595300 |
| 162 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.75554244 |
| 163 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.75526721 |
| 164 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.74766469 |
| 165 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.74580710 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 3.60262632 |
| 2 | MP0003436_decreased_susceptibility_to | 3.21524080 |
| 3 | MP0005451_abnormal_body_composition | 3.10395865 |
| 4 | MP0003303_peritoneal_inflammation | 2.83258629 |
| 5 | * MP0005464_abnormal_platelet_physiology | 2.60525443 |
| 6 | MP0004859_abnormal_synaptic_plasticity | 2.57261491 |
| 7 | MP0000920_abnormal_myelination | 2.55659521 |
| 8 | MP0000013_abnormal_adipose_tissue | 2.50103629 |
| 9 | MP0001835_abnormal_antigen_presentation | 2.46656335 |
| 10 | MP0004270_analgesia | 2.40236408 |
| 11 | MP0000747_muscle_weakness | 2.35330386 |
| 12 | MP0002822_catalepsy | 2.34294219 |
| 13 | MP0004130_abnormal_muscle_cell | 2.23145433 |
| 14 | MP0003172_abnormal_lysosome_physiology | 2.20971379 |
| 15 | MP0010234_abnormal_vibrissa_follicle | 2.18411529 |
| 16 | MP0004185_abnormal_adipocyte_glucose | 2.17962671 |
| 17 | MP0005410_abnormal_fertilization | 2.15524465 |
| 18 | MP0003329_amyloid_beta_deposits | 2.14144600 |
| 19 | MP0005000_abnormal_immune_tolerance | 2.11075979 |
| 20 | MP0003690_abnormal_glial_cell | 2.08944475 |
| 21 | * MP0000685_abnormal_immune_system | 2.05019541 |
| 22 | MP0000751_myopathy | 2.02634104 |
| 23 | MP0002419_abnormal_innate_immunity | 2.02077788 |
| 24 | * MP0001800_abnormal_humoral_immune | 2.00652163 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 1.97232862 |
| 26 | MP0005025_abnormal_response_to | 1.92580168 |
| 27 | MP0004036_abnormal_muscle_relaxation | 1.91689985 |
| 28 | MP0002796_impaired_skin_barrier | 1.91149799 |
| 29 | MP0000749_muscle_degeneration | 1.89338713 |
| 30 | MP0003635_abnormal_synaptic_transmissio | 1.83980117 |
| 31 | MP0008569_lethality_at_weaning | 1.83293740 |
| 32 | MP0010678_abnormal_skin_adnexa | 1.83257104 |
| 33 | MP0005671_abnormal_response_to | 1.81585447 |
| 34 | MP0001501_abnormal_sleep_pattern | 1.80471576 |
| 35 | MP0003300_gastrointestinal_ulcer | 1.80174683 |
| 36 | MP0008260_abnormal_autophagy | 1.78989338 |
| 37 | * MP0002420_abnormal_adaptive_immunity | 1.76946812 |
| 38 | MP0008961_abnormal_basal_metabolism | 1.76202251 |
| 39 | * MP0002723_abnormal_immune_serum | 1.75448626 |
| 40 | * MP0001819_abnormal_immune_cell | 1.73238622 |
| 41 | MP0000383_abnormal_hair_follicle | 1.72003510 |
| 42 | * MP0002452_abnormal_antigen_presenting | 1.71118638 |
| 43 | MP0005670_abnormal_white_adipose | 1.65753138 |
| 44 | MP0003566_abnormal_cell_adhesion | 1.61462011 |
| 45 | MP0000003_abnormal_adipose_tissue | 1.61461159 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.61342514 |
| 47 | MP0009840_abnormal_foam_cell | 1.59958989 |
| 48 | MP0009785_altered_susceptibility_to | 1.57664097 |
| 49 | MP0009278_abnormal_bone_marrow | 1.56838659 |
| 50 | MP0004510_myositis | 1.56779571 |
| 51 | MP0003705_abnormal_hypodermis_morpholog | 1.56329231 |
| 52 | MP0002064_seizures | 1.54863937 |
| 53 | MP0009745_abnormal_behavioral_response | 1.54301982 |
| 54 | * MP0002398_abnormal_bone_marrow | 1.53700229 |
| 55 | MP0009333_abnormal_splenocyte_physiolog | 1.52185989 |
| 56 | MP0002272_abnormal_nervous_system | 1.48968023 |
| 57 | MP0003880_abnormal_central_pattern | 1.48807918 |
| 58 | MP0005375_adipose_tissue_phenotype | 1.48573992 |
| 59 | MP0001486_abnormal_startle_reflex | 1.44511822 |
| 60 | MP0003828_pulmonary_edema | 1.42278503 |
| 61 | MP0005666_abnormal_adipose_tissue | 1.42221473 |
| 62 | MP0000465_gastrointestinal_hemorrhage | 1.41861754 |
| 63 | MP0002837_dystrophic_cardiac_calcinosis | 1.41072652 |
| 64 | MP0003091_abnormal_cell_migration | 1.40940735 |
| 65 | * MP0000716_abnormal_immune_system | 1.39903737 |
| 66 | MP0010155_abnormal_intestine_physiology | 1.39570830 |
| 67 | MP0002405_respiratory_system_inflammati | 1.37580636 |
| 68 | MP0000759_abnormal_skeletal_muscle | 1.35454409 |
| 69 | MP0002396_abnormal_hematopoietic_system | 1.34956152 |
| 70 | MP0006082_CNS_inflammation | 1.34532692 |
| 71 | MP0000604_amyloidosis | 1.33539529 |
| 72 | MP0002106_abnormal_muscle_physiology | 1.33027246 |
| 73 | MP0004381_abnormal_hair_follicle | 1.31032164 |
| 74 | * MP0001851_eye_inflammation | 1.30654295 |
| 75 | MP0009046_muscle_twitch | 1.30529042 |
| 76 | MP0000858_altered_metastatic_potential | 1.29833077 |
| 77 | MP0005397_hematopoietic_system_phenotyp | 1.28713849 |
| 78 | MP0001545_abnormal_hematopoietic_system | 1.28713849 |
| 79 | * MP0002148_abnormal_hypersensitivity_rea | 1.25588578 |
| 80 | MP0002998_abnormal_bone_remodeling | 1.25436532 |
| 81 | MP0003633_abnormal_nervous_system | 1.23803528 |
| 82 | MP0002971_abnormal_brown_adipose | 1.23304366 |
| 83 | * MP0000689_abnormal_spleen_morphology | 1.20399799 |
| 84 | * MP0002722_abnormal_immune_system | 1.19051056 |
| 85 | MP0003866_abnormal_defecation | 1.18978848 |
| 86 | MP0004885_abnormal_endolymph | 1.17992282 |
| 87 | MP0001845_abnormal_inflammatory_respons | 1.17279781 |
| 88 | MP0002234_abnormal_pharynx_morphology | 1.16864886 |
| 89 | * MP0003045_fibrosis | 1.16015682 |
| 90 | MP0003656_abnormal_erythrocyte_physiolo | 1.15707716 |
| 91 | MP0000703_abnormal_thymus_morphology | 1.15290981 |
| 92 | MP0004087_abnormal_muscle_fiber | 1.14645530 |
| 93 | * MP0002429_abnormal_blood_cell | 1.13335308 |
| 94 | MP0005369_muscle_phenotype | 1.13179672 |
| 95 | MP0005166_decreased_susceptibility_to | 1.11869905 |
| 96 | MP0002132_abnormal_respiratory_system | 1.11436682 |
| 97 | MP0002063_abnormal_learning/memory/cond | 1.11436320 |
| 98 | MP0001440_abnormal_grooming_behavior | 1.10914530 |
| 99 | MP0002909_abnormal_adrenal_gland | 1.10225551 |
| 100 | MP0004742_abnormal_vestibular_system | 1.09119891 |
| 101 | MP0002933_joint_inflammation | 1.05728780 |
| 102 | MP0008438_abnormal_cutaneous_collagen | 1.05491245 |
| 103 | MP0003279_aneurysm | 1.05399504 |
| 104 | MP0002572_abnormal_emotion/affect_behav | 1.05049561 |
| 105 | * MP0004947_skin_inflammation | 1.04580979 |
| 106 | MP0005409_darkened_coat_color | 1.04272698 |
| 107 | MP0005310_abnormal_salivary_gland | 1.03885387 |
| 108 | MP0003763_abnormal_thymus_physiology | 1.02253572 |
| 109 | MP0002166_altered_tumor_susceptibility | 1.02148517 |
| 110 | MP0001958_emphysema | 1.02099107 |
| 111 | MP0005620_abnormal_muscle_contractility | 1.00722147 |
| 112 | MP0001661_extended_life_span | 1.00442987 |
| 113 | MP0008469_abnormal_protein_level | 1.00254404 |
| 114 | MP0002138_abnormal_hepatobiliary_system | 0.98203029 |
| 115 | MP0004883_abnormal_blood_vessel | 0.97176724 |
| 116 | MP0002009_preneoplasia | 0.97003349 |
| 117 | MP0002332_abnormal_exercise_endurance | 0.96377331 |
| 118 | MP0005023_abnormal_wound_healing | 0.96029461 |
| 119 | MP0005535_abnormal_body_temperature | 0.95267976 |
| 120 | MP0002269_muscular_atrophy | 0.95255404 |
| 121 | MP0005058_abnormal_lysosome_morphology | 0.94674058 |
| 122 | MP0004808_abnormal_hematopoietic_stem | 0.93771345 |
| 123 | MP0003191_abnormal_cellular_cholesterol | 0.93249571 |
| 124 | MP0000249_abnormal_blood_vessel | 0.92962199 |
| 125 | MP0002118_abnormal_lipid_homeostasis | 0.92154466 |
| 126 | MP0003634_abnormal_glial_cell | 0.92092942 |
| 127 | MP0002060_abnormal_skin_morphology | 0.91713173 |
| 128 | * MP0001765_abnormal_ion_homeostasis | 0.91569513 |
| 129 | MP0008874_decreased_physiological_sensi | 0.90090001 |
| 130 | MP0005423_abnormal_somatic_nervous | 0.89049897 |
| 131 | MP0005167_abnormal_blood-brain_barrier | 0.88019192 |
| 132 | MP0002254_reproductive_system_inflammat | 0.87656608 |
| 133 | MP0003075_altered_response_to | 0.87061421 |
| 134 | MP0001666_abnormal_nutrient_absorption | 0.86874772 |
| 135 | MP0003950_abnormal_plasma_membrane | 0.86275301 |
| 136 | MP0002139_abnormal_hepatobiliary_system | 0.86108474 |
| 137 | MP0003724_increased_susceptibility_to | 0.85636233 |
| 138 | MP0003631_nervous_system_phenotype | 0.85531151 |
| 139 | MP0005164_abnormal_response_to | 0.85235874 |
| 140 | MP0005275_abnormal_skin_tensile | 0.84401308 |
| 141 | MP0004043_abnormal_pH_regulation | 0.84034169 |
| 142 | MP0005076_abnormal_cell_differentiation | 0.83633899 |
| 143 | MP0002877_abnormal_melanocyte_morpholog | 0.82976857 |
| 144 | MP0000647_abnormal_sebaceous_gland | 0.82584076 |
| 145 | MP0002734_abnormal_mechanical_nocicepti | 0.81000791 |
| 146 | MP0001502_abnormal_circadian_rhythm | 0.80937264 |
| 147 | MP0002108_abnormal_muscle_morphology | 0.80869684 |
| 148 | MP0010771_integument_phenotype | 0.80227103 |
| 149 | MP0001216_abnormal_epidermal_layer | 0.79487784 |
| 150 | MP0001849_ear_inflammation | 0.79170464 |
| 151 | MP0003195_calcinosis | 0.78977633 |
| 152 | MP0005334_abnormal_fat_pad | 0.78577381 |
| 153 | MP0003453_abnormal_keratinocyte_physiol | 0.76923875 |
| 154 | * MP0001790_abnormal_immune_system | 0.74551819 |
| 155 | * MP0005387_immune_system_phenotype | 0.74551819 |
| 156 | MP0002229_neurodegeneration | 0.74489168 |
| 157 | MP0002006_tumorigenesis | 0.74070665 |
| 158 | MP0004233_abnormal_muscle_weight | 0.72695255 |
| 159 | MP0001970_abnormal_pain_threshold | 0.72558751 |
| 160 | MP0000427_abnormal_hair_cycle | 0.72470454 |
| 161 | MP0003646_muscle_fatigue | 0.71258939 |
| 162 | MP0003183_abnormal_peptide_metabolism | 0.70330307 |
| 163 | MP0000579_abnormal_nail_morphology | 0.69233674 |
| 164 | MP0002067_abnormal_sensory_capabilities | 0.68574799 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 5.90357703 |
| 2 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.53546859 |
| 3 | Nemaline bodies (HP:0003798) | 5.45696226 |
| 4 | * Exercise-induced myalgia (HP:0003738) | 4.58843663 |
| 5 | Type 1 muscle fiber predominance (HP:0003803) | 4.45977012 |
| 6 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.11842463 |
| 7 | Neurofibrillary tangles (HP:0002185) | 4.02319646 |
| 8 | Myopathic facies (HP:0002058) | 4.02094085 |
| 9 | Difficulty running (HP:0009046) | 3.95973113 |
| 10 | Eczematoid dermatitis (HP:0000976) | 3.95755192 |
| 11 | Round ear (HP:0100830) | 3.92392985 |
| 12 | Distal arthrogryposis (HP:0005684) | 3.83062264 |
| 13 | Calf muscle hypertrophy (HP:0008981) | 3.60261436 |
| 14 | * Hyporeflexia of lower limbs (HP:0002600) | 3.59699134 |
| 15 | Prolonged bleeding time (HP:0003010) | 3.58300378 |
| 16 | Ulnar deviation of the wrist (HP:0003049) | 3.29985830 |
| 17 | Cerebral inclusion bodies (HP:0100314) | 3.29176895 |
| 18 | Exercise-induced muscle cramps (HP:0003710) | 3.10357646 |
| 19 | Increased IgE level (HP:0003212) | 3.06609977 |
| 20 | Muscle fiber splitting (HP:0003555) | 3.00967182 |
| 21 | Nasal polyposis (HP:0100582) | 3.00959875 |
| 22 | Hyperkalemia (HP:0002153) | 3.00885104 |
| 23 | Abnormality of macrophages (HP:0004311) | 3.00398590 |
| 24 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.98805841 |
| 25 | Ankle clonus (HP:0011448) | 2.87980230 |
| 26 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.87681797 |
| 27 | Gingival bleeding (HP:0000225) | 2.86391550 |
| 28 | Absent/shortened dynein arms (HP:0200106) | 2.84700242 |
| 29 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.84700242 |
| 30 | Myositis (HP:0100614) | 2.82234031 |
| 31 | Recurrent abscess formation (HP:0002722) | 2.81927312 |
| 32 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.78631607 |
| 33 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.78631607 |
| 34 | Purpura (HP:0000979) | 2.76687911 |
| 35 | Supranuclear gaze palsy (HP:0000605) | 2.72435891 |
| 36 | Spontaneous hematomas (HP:0007420) | 2.70128117 |
| 37 | * Epistaxis (HP:0000421) | 2.70087825 |
| 38 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.69011905 |
| 39 | Recurrent bacterial skin infections (HP:0005406) | 2.68775358 |
| 40 | Neck muscle weakness (HP:0000467) | 2.67156961 |
| 41 | Abnormality of the nasal mucosa (HP:0000433) | 2.66631984 |
| 42 | Cellulitis (HP:0100658) | 2.60270412 |
| 43 | Frequent falls (HP:0002359) | 2.58861580 |
| 44 | Petechiae (HP:0000967) | 2.56803869 |
| 45 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.56528255 |
| 46 | Abnormal platelet volume (HP:0011876) | 2.54683466 |
| 47 | Bulbar palsy (HP:0001283) | 2.54443725 |
| 48 | Dysostosis multiplex (HP:0000943) | 2.53586583 |
| 49 | Facial diplegia (HP:0001349) | 2.52392318 |
| 50 | Menorrhagia (HP:0000132) | 2.44918400 |
| 51 | EMG: myopathic abnormalities (HP:0003458) | 2.43000876 |
| 52 | Orchitis (HP:0100796) | 2.42763626 |
| 53 | Abnormal ciliary motility (HP:0012262) | 2.42667807 |
| 54 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.41959181 |
| 55 | Intention tremor (HP:0002080) | 2.41644886 |
| 56 | * Abnormality of skeletal muscle fiber size (HP:0012084) | 2.41310494 |
| 57 | Recurrent fungal infections (HP:0002841) | 2.39445329 |
| 58 | Abnormality of the neuromuscular junction (HP:0003398) | 2.39400590 |
| 59 | Fatigable weakness (HP:0003473) | 2.39400590 |
| 60 | Meningitis (HP:0001287) | 2.38315761 |
| 61 | Gastrointestinal infarctions (HP:0005244) | 2.36736505 |
| 62 | Gastrointestinal inflammation (HP:0004386) | 2.35348167 |
| 63 | Absent phalangeal crease (HP:0006109) | 2.34644789 |
| 64 | Myoglobinuria (HP:0002913) | 2.32665133 |
| 65 | Deep venous thrombosis (HP:0002625) | 2.32577407 |
| 66 | Chronic otitis media (HP:0000389) | 2.30958290 |
| 67 | Obstructive sleep apnea (HP:0002870) | 2.29599303 |
| 68 | Papilledema (HP:0001085) | 2.29412996 |
| 69 | Colitis (HP:0002583) | 2.27679380 |
| 70 | Male infertility (HP:0003251) | 2.26319401 |
| 71 | Rhinitis (HP:0012384) | 2.26215275 |
| 72 | Inflammation of the large intestine (HP:0002037) | 2.25709898 |
| 73 | * Increased variability in muscle fiber diameter (HP:0003557) | 2.25699397 |
| 74 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.24796361 |
| 75 | * Muscle stiffness (HP:0003552) | 2.23243103 |
| 76 | Gowers sign (HP:0003391) | 2.21558381 |
| 77 | Asymmetric septal hypertrophy (HP:0001670) | 2.20249080 |
| 78 | Spastic gait (HP:0002064) | 2.19793884 |
| 79 | Focal motor seizures (HP:0011153) | 2.19079808 |
| 80 | Increased mean platelet volume (HP:0011877) | 2.16057007 |
| 81 | Obstructive lung disease (HP:0006536) | 2.15655358 |
| 82 | Chronic obstructive pulmonary disease (HP:0006510) | 2.15655358 |
| 83 | Abnormality of the corticospinal tract (HP:0002492) | 2.15497392 |
| 84 | Polycythemia (HP:0001901) | 2.15471890 |
| 85 | Calcaneovalgus deformity (HP:0001848) | 2.15189945 |
| 86 | Onion bulb formation (HP:0003383) | 2.14117148 |
| 87 | Cerebral aneurysm (HP:0004944) | 2.13990649 |
| 88 | Stridor (HP:0010307) | 2.13448758 |
| 89 | Abnormal finger flexion creases (HP:0006143) | 2.12418274 |
| 90 | Distal lower limb muscle weakness (HP:0009053) | 2.11457712 |
| 91 | Recurrent viral infections (HP:0004429) | 2.11098503 |
| 92 | Pustule (HP:0200039) | 2.11013656 |
| 93 | Hemorrhage of the eye (HP:0011885) | 2.10400141 |
| 94 | Stomatitis (HP:0010280) | 2.10310086 |
| 95 | Mediastinal lymphadenopathy (HP:0100721) | 2.10293333 |
| 96 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.09243164 |
| 97 | Mucopolysacchariduria (HP:0008155) | 2.09243164 |
| 98 | Rhabdomyolysis (HP:0003201) | 2.08324162 |
| 99 | Distal lower limb amyotrophy (HP:0008944) | 2.07757672 |
| 100 | Chest pain (HP:0100749) | 2.07576028 |
| 101 | Gingivitis (HP:0000230) | 2.06993072 |
| 102 | Neuronal loss in central nervous system (HP:0002529) | 2.06798133 |
| 103 | Agammaglobulinemia (HP:0004432) | 2.06008451 |
| 104 | Abnormality of the calf musculature (HP:0001430) | 2.05049818 |
| 105 | Fatigue (HP:0012378) | 2.03585662 |
| 106 | Clumsiness (HP:0002312) | 2.03427496 |
| 107 | Vasculitis (HP:0002633) | 2.02886827 |
| 108 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.02478190 |
| 109 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.02478190 |
| 110 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.02478190 |
| 111 | Panhypogammaglobulinemia (HP:0003139) | 2.01697872 |
| 112 | Optic neuritis (HP:0100653) | 2.01591226 |
| 113 | Retrobulbar optic neuritis (HP:0100654) | 2.01591226 |
| 114 | Dysmetria (HP:0001310) | 2.01293577 |
| 115 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.99140384 |
| 116 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.99140384 |
| 117 | Amyloidosis (HP:0011034) | 1.97183561 |
| 118 | Rapidly progressive (HP:0003678) | 1.96858762 |
| 119 | Hyperlipoproteinemia (HP:0010980) | 1.95648797 |
| 120 | Deformed tarsal bones (HP:0008119) | 1.93270695 |
| 121 | Urinary urgency (HP:0000012) | 1.93207864 |
| 122 | Nonprogressive disorder (HP:0003680) | 1.92738012 |
| 123 | Abnormality of the common coagulation pathway (HP:0010990) | 1.92233926 |
| 124 | Systemic lupus erythematosus (HP:0002725) | 1.92168366 |
| 125 | Peritonitis (HP:0002586) | 1.91711167 |
| 126 | Joint hemorrhage (HP:0005261) | 1.91650694 |
| 127 | Papilloma (HP:0012740) | 1.91166773 |
| 128 | Verrucae (HP:0200043) | 1.91166773 |
| 129 | Recurrent skin infections (HP:0001581) | 1.91047367 |
| 130 | Visual hallucinations (HP:0002367) | 1.90477268 |
| 131 | Increased connective tissue (HP:0009025) | 1.90093169 |
| 132 | Milia (HP:0001056) | 1.90058277 |
| 133 | Gastrointestinal stroma tumor (HP:0100723) | 1.89899469 |
| 134 | Difficulty climbing stairs (HP:0003551) | 1.88868522 |
| 135 | Granulocytopenia (HP:0001913) | 1.88612814 |
| 136 | Lower limb muscle weakness (HP:0007340) | 1.87092337 |
| 137 | Insidious onset (HP:0003587) | 1.86893770 |
| 138 | Termporal pattern (HP:0011008) | 1.86893770 |
| 139 | Rimmed vacuoles (HP:0003805) | 1.85657788 |
| 140 | Infertility (HP:0000789) | 1.85303915 |
| 141 | Impaired platelet aggregation (HP:0003540) | 1.83598473 |
| 142 | Abnormal platelet function (HP:0011869) | 1.83598473 |
| 143 | Hypertriglyceridemia (HP:0002155) | 1.82949838 |
| 144 | Chronic bronchitis (HP:0004469) | 1.82664802 |
| 145 | Broad face (HP:0000283) | 1.82226309 |
| 146 | Interstitial pulmonary disease (HP:0006530) | 1.82020154 |
| 147 | Arterial thrombosis (HP:0004420) | 1.81890086 |
| 148 | Malignant hyperthermia (HP:0002047) | 1.81516713 |
| 149 | Bundle branch block (HP:0011710) | 1.81137833 |
| 150 | Proximal amyotrophy (HP:0007126) | 1.80684723 |
| 151 | Urticaria (HP:0001025) | 1.79975376 |
| 152 | Atonic seizures (HP:0010819) | 1.78139738 |
| 153 | Dilatation of the ascending aorta (HP:0005111) | 1.77768036 |
| 154 | Bruising susceptibility (HP:0000978) | 1.77645977 |
| 155 | Generalized tonic-clonic seizures (HP:0002069) | 1.74647986 |
| 156 | Achilles tendon contracture (HP:0001771) | 1.74559241 |
| 157 | Scapular winging (HP:0003691) | 1.74247906 |
| 158 | Slender build (HP:0001533) | 1.74134811 |
| 159 | Myotonia (HP:0002486) | 1.73897932 |
| 160 | Lower limb amyotrophy (HP:0007210) | 1.73870350 |
| 161 | Keratoconjunctivitis sicca (HP:0001097) | 1.73636931 |
| 162 | Loss of speech (HP:0002371) | 1.73399662 |
| 163 | Bronchiectasis (HP:0002110) | 1.72885599 |
| 164 | EMG: neuropathic changes (HP:0003445) | 1.72598360 |
| 165 | Slow saccadic eye movements (HP:0000514) | 1.72495734 |
| 166 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.71949011 |
| 167 | Increased cerebral lipofuscin (HP:0011813) | 1.71599658 |
| 168 | Recurrent cutaneous fungal infections (HP:0011370) | 1.71362556 |
| 169 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.71362556 |
| 170 | Increased serum ferritin (HP:0003281) | 1.71203851 |
| 171 | Encephalitis (HP:0002383) | 1.70728895 |
| 172 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.70447737 |
| 173 | Clonus (HP:0002169) | 1.69118187 |
| 174 | Weak cry (HP:0001612) | 1.68639380 |
| 175 | Hemiplegia (HP:0002301) | 1.67246134 |
| 176 | Spastic tetraparesis (HP:0001285) | 1.67018878 |
| 177 | Parakeratosis (HP:0001036) | 1.66195133 |
| 178 | Acanthosis nigricans (HP:0000956) | 1.65202830 |
| 179 | Lip pit (HP:0100267) | 1.64883819 |
| 180 | Focal seizures (HP:0007359) | 1.64288321 |
| 181 | Action tremor (HP:0002345) | 1.61795801 |
| 182 | T lymphocytopenia (HP:0005403) | 1.59972375 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 2.88133018 |
| 2 | EPHB1 | 2.60837202 |
| 3 | STK39 | 2.05833095 |
| 4 | CAMK1G | 1.87992384 |
| 5 | TTN | 1.87209600 |
| 6 | PIK3CG | 1.86779999 |
| 7 | MAPKAPK5 | 1.77501215 |
| 8 | RIPK1 | 1.71587742 |
| 9 | MAP4K1 | 1.69274127 |
| 10 | DMPK | 1.61057066 |
| 11 | FGFR2 | 1.59821889 |
| 12 | TNIK | 1.59603027 |
| 13 | PHKG2 | 1.57160934 |
| 14 | PHKG1 | 1.57160934 |
| 15 | ICK | 1.54689127 |
| 16 | NTRK3 | 1.53762869 |
| 17 | MAP3K2 | 1.53290271 |
| 18 | MAP3K3 | 1.52571589 |
| 19 | MAPK15 | 1.51566638 |
| 20 | TAOK3 | 1.51416395 |
| 21 | TYRO3 | 1.50248094 |
| 22 | CDK12 | 1.48485504 |
| 23 | ITK | 1.47297050 |
| 24 | PNCK | 1.43690224 |
| 25 | EPHA4 | 1.43292186 |
| 26 | TNK2 | 1.42578974 |
| 27 | BLK | 1.40142482 |
| 28 | TRIB3 | 1.40077769 |
| 29 | TBK1 | 1.39193568 |
| 30 | MAP3K13 | 1.37200293 |
| 31 | GRK6 | 1.35751282 |
| 32 | BMPR2 | 1.34484503 |
| 33 | MAP3K7 | 1.33835427 |
| 34 | BTK | 1.33809587 |
| 35 | MAP3K9 | 1.33505980 |
| 36 | MAP3K14 | 1.33071590 |
| 37 | SMG1 | 1.30429740 |
| 38 | IRAK4 | 1.30338563 |
| 39 | WNK1 | 1.29552957 |
| 40 | KSR2 | 1.28093391 |
| 41 | RIPK4 | 1.21636415 |
| 42 | JAK3 | 1.21239229 |
| 43 | PRKCH | 1.19320539 |
| 44 | OXSR1 | 1.18230385 |
| 45 | MARK2 | 1.17400057 |
| 46 | TXK | 1.15271364 |
| 47 | FES | 1.14487468 |
| 48 | MAP3K1 | 1.13725572 |
| 49 | NTRK1 | 1.11088446 |
| 50 | PDK1 | 1.07034036 |
| 51 | PRKD3 | 1.05110244 |
| 52 | IRAK3 | 1.03261958 |
| 53 | TAOK2 | 1.02979698 |
| 54 | PDK4 | 1.02216336 |
| 55 | PDK3 | 1.02216336 |
| 56 | NEK6 | 0.98848779 |
| 57 | JAK1 | 0.98379860 |
| 58 | INSRR | 0.97567531 |
| 59 | PRKCQ | 0.96363528 |
| 60 | RET | 0.95374730 |
| 61 | SIK3 | 0.94242908 |
| 62 | MAP2K4 | 0.93766434 |
| 63 | PDPK1 | 0.91754332 |
| 64 | PTK6 | 0.91154682 |
| 65 | STK11 | 0.91110389 |
| 66 | TAOK1 | 0.88805497 |
| 67 | MAPK12 | 0.88537921 |
| 68 | CSF1R | 0.87553730 |
| 69 | MAP3K11 | 0.87280612 |
| 70 | HIPK2 | 0.87156904 |
| 71 | MAPK11 | 0.84744500 |
| 72 | PAK6 | 0.84382432 |
| 73 | CDC42BPA | 0.84304878 |
| 74 | CAMK1D | 0.83690219 |
| 75 | SIK2 | 0.83010306 |
| 76 | SIK1 | 0.81315868 |
| 77 | STK38 | 0.81215653 |
| 78 | PTK2B | 0.80709388 |
| 79 | ERN1 | 0.79417992 |
| 80 | ARAF | 0.79186097 |
| 81 | MAP3K6 | 0.78386796 |
| 82 | NEK9 | 0.76760222 |
| 83 | MET | 0.76268461 |
| 84 | PDK2 | 0.75660001 |
| 85 | FGFR4 | 0.74134817 |
| 86 | KIT | 0.73976707 |
| 87 | PIK3CA | 0.72286057 |
| 88 | PKN1 | 0.72163219 |
| 89 | SGK3 | 0.72139700 |
| 90 | NTRK2 | 0.72081817 |
| 91 | IKBKE | 0.71634849 |
| 92 | MAP2K3 | 0.69691994 |
| 93 | CDK5 | 0.69413948 |
| 94 | MAP3K4 | 0.69250569 |
| 95 | DAPK2 | 0.67896174 |
| 96 | PRKD2 | 0.67643700 |
| 97 | MAP3K10 | 0.67355976 |
| 98 | PRPF4B | 0.67290895 |
| 99 | HCK | 0.66920176 |
| 100 | CSK | 0.66497312 |
| 101 | JAK2 | 0.66059346 |
| 102 | PRKD1 | 0.66039637 |
| 103 | MOS | 0.65438224 |
| 104 | TGFBR2 | 0.65053921 |
| 105 | MAPK7 | 0.63868107 |
| 106 | EPHA3 | 0.63244589 |
| 107 | LYN | 0.63063831 |
| 108 | MUSK | 0.61887626 |
| 109 | PDGFRB | 0.61735382 |
| 110 | CAMKK1 | 0.60442423 |
| 111 | MARK3 | 0.59572486 |
| 112 | BMX | 0.59138382 |
| 113 | TRPM7 | 0.57155236 |
| 114 | MST1R | 0.57093963 |
| 115 | PKN2 | 0.57073506 |
| 116 | IRAK1 | 0.57005392 |
| 117 | EEF2K | 0.56871722 |
| 118 | FYN | 0.56291156 |
| 119 | TYK2 | 0.56191561 |
| 120 | WNK4 | 0.53529088 |
| 121 | STK10 | 0.53525925 |
| 122 | TEC | 0.53291096 |
| 123 | FGFR3 | 0.53054685 |
| 124 | MAP2K2 | 0.52860211 |
| 125 | TESK2 | 0.51728044 |
| 126 | IKBKB | 0.51036838 |
| 127 | PINK1 | 0.50531393 |
| 128 | SYK | 0.50242381 |
| 129 | CDK19 | 0.49689731 |
| 130 | LCK | 0.49477934 |
| 131 | LRRK2 | 0.48944422 |
| 132 | SGK1 | 0.48687241 |
| 133 | CAMK2G | 0.48458871 |
| 134 | PAK3 | 0.48264391 |
| 135 | LMTK2 | 0.48056174 |
| 136 | ZAP70 | 0.47475813 |
| 137 | RAF1 | 0.46967913 |
| 138 | NME1 | 0.46356096 |
| 139 | IRAK2 | 0.46179756 |
| 140 | FGR | 0.45781684 |
| 141 | MAPK4 | 0.44882813 |
| 142 | NLK | 0.42693935 |
| 143 | MTOR | 0.41467479 |
| 144 | RPS6KA2 | 0.40762175 |
| 145 | RPS6KC1 | 0.39004611 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 2.12991689 |
| 2 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.92509257 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 1.74126021 |
| 4 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.70565116 |
| 5 | Renin secretion_Homo sapiens_hsa04924 | 1.69157845 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.63876149 |
| 7 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.61978943 |
| 8 | Salivary secretion_Homo sapiens_hsa04970 | 1.60877663 |
| 9 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.58254636 |
| 10 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.50598247 |
| 11 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.41560559 |
| 12 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.40135372 |
| 13 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.39833912 |
| 14 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.38460320 |
| 15 | Long-term potentiation_Homo sapiens_hsa04720 | 1.38302326 |
| 16 | Circadian entrainment_Homo sapiens_hsa04713 | 1.38057510 |
| 17 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.34713688 |
| 18 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.33106774 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.32991532 |
| 20 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.32681481 |
| 21 | Olfactory transduction_Homo sapiens_hsa04740 | 1.31992630 |
| 22 | GABAergic synapse_Homo sapiens_hsa04727 | 1.31682353 |
| 23 | Insulin secretion_Homo sapiens_hsa04911 | 1.30968261 |
| 24 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.30779953 |
| 25 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.29823890 |
| 26 | Morphine addiction_Homo sapiens_hsa05032 | 1.29585334 |
| 27 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.29585185 |
| 28 | Tuberculosis_Homo sapiens_hsa05152 | 1.29220224 |
| 29 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.27617085 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.26073895 |
| 31 | Allograft rejection_Homo sapiens_hsa05330 | 1.25809142 |
| 32 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.25778684 |
| 33 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.25311219 |
| 34 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.24339799 |
| 35 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.21955686 |
| 36 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.21080366 |
| 37 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.18735223 |
| 38 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.18330338 |
| 39 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.18233411 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.18178470 |
| 41 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.15248703 |
| 42 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.13200614 |
| 43 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.12643916 |
| 44 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.11981908 |
| 45 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.11889692 |
| 46 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.11199155 |
| 47 | Measles_Homo sapiens_hsa05162 | 1.10782770 |
| 48 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.10725465 |
| 49 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.10486288 |
| 50 | Viral myocarditis_Homo sapiens_hsa05416 | 1.10216487 |
| 51 | Cocaine addiction_Homo sapiens_hsa05030 | 1.09366464 |
| 52 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.07029436 |
| 53 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.05975960 |
| 54 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.04480710 |
| 55 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.04274731 |
| 56 | Malaria_Homo sapiens_hsa05144 | 1.03693425 |
| 57 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.03469209 |
| 58 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.99942539 |
| 59 | ABC transporters_Homo sapiens_hsa02010 | 0.99912282 |
| 60 | Long-term depression_Homo sapiens_hsa04730 | 0.99497938 |
| 61 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.98193746 |
| 62 | Influenza A_Homo sapiens_hsa05164 | 0.97545913 |
| 63 | Insulin resistance_Homo sapiens_hsa04931 | 0.97513444 |
| 64 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.96455265 |
| 65 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.96148545 |
| 66 | Endometrial cancer_Homo sapiens_hsa05213 | 0.95084886 |
| 67 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.94593493 |
| 68 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.94552888 |
| 69 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.94333373 |
| 70 | Hepatitis B_Homo sapiens_hsa05161 | 0.94035542 |
| 71 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.92074229 |
| 72 | Hepatitis C_Homo sapiens_hsa05160 | 0.90756811 |
| 73 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.90719333 |
| 74 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.90618029 |
| 75 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.90465500 |
| 76 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.90326546 |
| 77 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.89253127 |
| 78 | Taste transduction_Homo sapiens_hsa04742 | 0.87320345 |
| 79 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.87173641 |
| 80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.87037041 |
| 81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.85647764 |
| 82 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.85315245 |
| 83 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.84536674 |
| 84 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.84235234 |
| 85 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.84010021 |
| 86 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.83385560 |
| 87 | Circadian rhythm_Homo sapiens_hsa04710 | 0.83093090 |
| 88 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.82946798 |
| 89 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.82584826 |
| 90 | Pertussis_Homo sapiens_hsa05133 | 0.82480110 |
| 91 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.81304281 |
| 92 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.80553786 |
| 93 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.78818682 |
| 94 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.78617451 |
| 95 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.76295340 |
| 96 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.75675761 |
| 97 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75507092 |
| 98 | Nicotine addiction_Homo sapiens_hsa05033 | 0.74879366 |
| 99 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.74154825 |
| 100 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.73740418 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.73403056 |
| 102 | Apoptosis_Homo sapiens_hsa04210 | 0.73374063 |
| 103 | * Platelet activation_Homo sapiens_hsa04611 | 0.73016849 |
| 104 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.72453172 |
| 105 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.72050384 |
| 106 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.71402050 |
| 107 | Bile secretion_Homo sapiens_hsa04976 | 0.71116928 |
| 108 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.71092623 |
| 109 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.69917436 |
| 110 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.69036904 |
| 111 | Endocytosis_Homo sapiens_hsa04144 | 0.69000016 |
| 112 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.68663571 |
| 113 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68416124 |
| 114 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.67783492 |
| 115 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.67410462 |
| 116 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.66900766 |
| 117 | Prion diseases_Homo sapiens_hsa05020 | 0.66641952 |
| 118 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64828763 |
| 119 | Axon guidance_Homo sapiens_hsa04360 | 0.64485073 |
| 120 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.64330822 |
| 121 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.63912124 |
| 122 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.63851384 |
| 123 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.62999853 |
| 124 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.62149927 |
| 125 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.61937977 |
| 126 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.61755390 |
| 127 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.61455038 |
| 128 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.61148415 |
| 129 | Shigellosis_Homo sapiens_hsa05131 | 0.60839432 |
| 130 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.60546831 |
| 131 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.60504450 |
| 132 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.60245519 |
| 133 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.60104687 |
| 134 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.59942586 |
| 135 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.59633804 |
| 136 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.58688590 |
| 137 | Phagosome_Homo sapiens_hsa04145 | 0.57538168 |
| 138 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.57407841 |
| 139 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.57116373 |
| 140 | Amoebiasis_Homo sapiens_hsa05146 | 0.57058965 |
| 141 | Prostate cancer_Homo sapiens_hsa05215 | 0.56606632 |
| 142 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.54680311 |
| 143 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.54347525 |
| 144 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.52657600 |
| 145 | Melanogenesis_Homo sapiens_hsa04916 | 0.52615229 |
| 146 | Lysosome_Homo sapiens_hsa04142 | 0.52504416 |
| 147 | Thyroid cancer_Homo sapiens_hsa05216 | 0.51969983 |
| 148 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.50025392 |
| 149 | Focal adhesion_Homo sapiens_hsa04510 | 0.48252542 |
| 150 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48205539 |
| 151 | Gap junction_Homo sapiens_hsa04540 | 0.47420846 |
| 152 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.46056946 |
| 153 | Glioma_Homo sapiens_hsa05214 | 0.44755927 |

